14-62707562-A-G
Variant names:
Variant summary
Our verdict is Likely benign. The variant received -5 ACMG points: 2P and 7B. PM2BP4_StrongBP6_ModerateBP7
The NM_139318.5(KCNH5):c.2913T>C(p.Phe971Phe) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000739 in 1,353,428 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: not found (cov: 32)
Exomes 𝑓: 7.4e-7 ( 0 hom. )
Consequence
KCNH5
NM_139318.5 synonymous
NM_139318.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.79
Publications
0 publications found
Genes affected
KCNH5 (HGNC:6254): (potassium voltage-gated channel subfamily H member 5) This gene encodes a member of voltage-gated potassium channels. Members of this family have diverse functions, including regulating neurotransmitter and hormone release, cardiac function, and cell volume. This protein is an outward-rectifying, noninactivating channel. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2013]
KCNH5 Gene-Disease associations (from GenCC):
- infantile-onset epilepsyInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- developmental and epileptic encephalopathy 112Inheritance: AD Classification: STRONG Submitted by: G2P
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -5 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.51).
BP6
Variant 14-62707562-A-G is Benign according to our data. Variant chr14-62707562-A-G is described in ClinVar as [Likely_benign]. Clinvar id is 2154524.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=1.79 with no splicing effect.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD2 exomes AF: 0.00 AC: 0AN: 179542 AF XY: 0.00
GnomAD2 exomes
AF:
AC:
0
AN:
179542
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 7.39e-7 AC: 1AN: 1353428Hom.: 0 Cov.: 29 AF XY: 0.00 AC XY: 0AN XY: 660552 show subpopulations
GnomAD4 exome
AF:
AC:
1
AN:
1353428
Hom.:
Cov.:
29
AF XY:
AC XY:
0
AN XY:
660552
show subpopulations
African (AFR)
AF:
AC:
0
AN:
30156
American (AMR)
AF:
AC:
1
AN:
29008
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
19894
East Asian (EAS)
AF:
AC:
0
AN:
38572
South Asian (SAS)
AF:
AC:
0
AN:
65690
European-Finnish (FIN)
AF:
AC:
0
AN:
49646
Middle Eastern (MID)
AF:
AC:
0
AN:
5280
European-Non Finnish (NFE)
AF:
AC:
0
AN:
1059446
Other (OTH)
AF:
AC:
0
AN:
55736
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
Alfa
AF:
Hom.:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Developmental and epileptic encephalopathy Benign:1
Mar 19, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.